Answer
Tyverb (lapatinib) increased oral digoxin exposure (AUC) by approximately 80% when co-administered.
Sources for this answer
- Tyverb film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 34Document updated
Sources checked